AYTU Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aytu Biopharma Inc (AYTU).


$16.26M Market Cap.

As of 09/30/2024 5:00 PM ET (MRY) • Disclaimer

AYTU Market Cap. (MRY)


AYTU Shares Outstanding (MRY)


AYTU Assets (MRY)


Total Assets

$118.09M

Total Liabilities

$90.38M

Total Investments

$0

AYTU Income (MRY)


Revenue

$81.00M

Net Income

-$15.84M

Operating Expense

$59.84M

AYTU Cash Flow (MRY)


CF Operations

-$1.39M

CF Investing

-$329.00K

CF Financing

-$1.26M

AYTU Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AYTU Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$118,095,000 (-13.46%)

$136,463,000 (-0.84%)

$137,623,000 (-48.20%)

$265,668,000 (73.31%)

Assets Current

$61,891,000 (-15.02%)

$72,832,000 (21.53%)

$59,929,000 (-43.05%)

$105,234,000 (39.53%)

Assets Non-Current

$56,204,000 (-11.67%)

$63,631,000 (-18.10%)

$77,694,000 (-51.57%)

$160,434,000 (106.03%)

Goodwill & Intangible Assets

$52,453,000 (-11.05%)

$58,970,000 (-16.51%)

$70,632,000 (-53.31%)

$151,266,000 (96.59%)

Shareholders Equity

$27,716,000 (-29.58%)

$39,357,000 (-11.17%)

$44,308,000 (-67.79%)

$137,568,000 (44.79%)

Property Plant & Equipment Net

$1,522,000 (-60.66%)

$3,869,000 (-38.55%)

$6,296,000 (-27.66%)

$8,703,000 (874.58%)

Cash & Equivalents

$20,006,000 (-12.96%)

$22,985,000 (18.72%)

$19,360,000 (-61.20%)

$49,901,000 (3.24%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$12,633,000 (5.32%)

$11,995,000 (10.56%)

$10,849,000 (-33.60%)

$16,339,000 (63.41%)

Trade & Non-Trade Receivables

$23,617,000 (-18.38%)

$28,937,000 (33.28%)

$21,712,000 (-22.94%)

$28,176,000 (400.20%)

Trade & Non-Trade Payables

$10,440,000 (-22.54%)

$13,478,000 (22.67%)

$10,987,000 (-42.94%)

$19,255,000 (65.42%)

Accumulated Retained Earnings (Deficit)

-$319,973,000 (-5.21%)

-$304,129,000 (-5.94%)

-$287,078,000 (-61.01%)

-$178,299,000 (-48.57%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$15,129,000 (-7.53%)

$16,361,000 (-10.05%)

$18,188,000 (-26.61%)

$24,782,000 (88.04%)

Debt Current

$4,252,000 (158.01%)

$1,648,000 (-57.84%)

$3,909,000 (-84.11%)

$24,602,000 (1819.03%)

Debt Non-Current

$10,877,000 (-26.07%)

$14,713,000 (3.04%)

$14,279,000 (7832.78%)

$180,000 (-98.49%)

Total Liabilities

$90,379,000 (-6.93%)

$97,106,000 (4.06%)

$93,315,000 (-27.15%)

$128,100,000 (119.81%)

Liabilities Current

$62,228,000 (-9.83%)

$69,015,000 (7.10%)

$64,442,000 (-41.12%)

$109,438,000 (280.48%)

Liabilities Non-Current

$28,151,000 (0.21%)

$28,091,000 (-2.71%)

$28,873,000 (54.72%)

$18,662,000 (-36.77%)

AYTU Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$81,002,000 (-24.58%)

$107,399,000 (11.10%)

$96,669,000 (47.29%)

$65,632,000 (137.52%)

Cost of Revenue

$26,416,000 (-35.20%)

$40,767,000 (-8.15%)

$44,386,000 (21.83%)

$36,432,000 (339.95%)

Selling General & Administrative Expense

$49,472,000 (-29.40%)

$70,078,000 (0.28%)

$69,880,000 (25.22%)

$55,808,000 (79.68%)

Research & Development Expense

$2,791,000 (-31.84%)

$4,095,000 (-67.66%)

$12,662,000 (125.18%)

$5,623,000 (226.54%)

Operating Expenses

$59,840,000 (-29.32%)

$84,666,000 (-48.33%)

$163,844,000 (86.04%)

$88,070,000 (117.55%)

Interest Expense

$4,792,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$1,768,000 (0%)

$0 (0%)

-$110,000 (-142.47%)

$259,000 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$15,844,000 (7.08%)

-$17,051,000 (84.33%)

-$108,779,000 (-86.62%)

-$58,289,000 (-327.93%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$15,844,000 (7.08%)

-$17,051,000 (84.33%)

-$108,779,000 (-86.62%)

-$58,289,000 (-327.93%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$15,844,000 (7.08%)

-$17,051,000 (84.33%)

-$108,779,000 (-86.62%)

-$58,289,000 (-327.93%)

Weighted Average Shares

$5,537,957 (65.81%)

$3,339,906 (127.22%)

$1,469,875 (75.54%)

$837,334 (270.57%)

Weighted Average Shares Diluted

$5,537,957 (65.81%)

$3,339,906 (127.22%)

$1,469,875 (75.54%)

$837,334 (270.57%)

Earning Before Interest & Taxes (EBIT)

-$9,284,000 (45.55%)

-$17,051,000 (84.34%)

-$108,889,000 (-87.64%)

-$58,030,000 (-326.03%)

Gross Profit

$54,586,000 (-18.08%)

$66,632,000 (27.44%)

$52,283,000 (79.05%)

$29,200,000 (50.90%)

Operating Income

-$5,254,000 (70.87%)

-$18,034,000 (83.83%)

-$111,561,000 (-89.50%)

-$58,870,000 (-178.60%)

AYTU Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$329,000 (-181.20%)

-$117,000 (96.40%)

-$3,248,000 (-16.75%)

-$2,782,000 (50.81%)

Net Cash Flow from Financing

-$1,262,000 (-114.23%)

$8,871,000 (479.80%)

$1,530,000 (-94.95%)

$30,314,000 (-57.35%)

Net Cash Flow from Operations

-$1,388,000 (72.94%)

-$5,129,000 (82.21%)

-$28,823,000 (-11.01%)

-$25,964,000 (8.49%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$2,979,000 (-182.18%)

$3,625,000 (111.87%)

-$30,541,000 (-2047.77%)

$1,568,000 (-95.77%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$5,000 (99.84%)

-$3,178,000 (-12.62%)

-$2,822,000 (50.16%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

-$4,729,000 (29.46%)

-$6,704,000 (34.00%)

-$10,157,000 (-3.34%)

-$9,829,000 (39.51%)

Issuance (Purchase) of Equity Shares

$3,467,000 (-77.74%)

$15,575,000 (33.19%)

$11,694,000 (-70.87%)

$40,148,000 (-33.45%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,913,000 (-51.82%)

$6,046,000 (15.21%)

$5,248,000 (46.84%)

$3,574,000 (231.23%)

Depreciation Amortization & Accretion

$8,272,000 (-6.16%)

$8,815,000 (-13.12%)

$10,146,000 (10.27%)

$9,201,000 (61.03%)

AYTU Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

67.40% (8.71%)

62.00% (14.60%)

54.10% (21.57%)

44.50% (-36.43%)

Profit Margin

-19.60% (-23.27%)

-15.90% (85.87%)

-112.50% (-26.69%)

-88.80% (-80.12%)

EBITDA Margin

-1.20% (84.42%)

-7.70% (92.46%)

-102.10% (-37.23%)

-74.40% (-160.14%)

Return on Average Equity (ROAE)

-51.30% (-31.20%)

-39.10% (71.02%)

-134.90% (-180.46%)

-48.10% (-76.19%)

Return on Average Assets (ROAA)

-12.40% (-4.20%)

-11.90% (79.27%)

-57.40% (-107.97%)

-27.60% (-112.31%)

Return on Sales (ROS)

-11.50% (27.67%)

-15.90% (85.88%)

-112.60% (-27.38%)

-88.40% (-79.31%)

Return on Invested Capital (ROIC)

-5389.80% (-1828.37%)

-279.50% (-108.28%)

3374.00% (504.46%)

-834.20% (64.66%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.02 (-226.20%)

-0.31 (-68.28%)

-0.19 (87.08%)

-1.44 (69.48%)

Price to Sales Ratio (P/S)

0.2 (300.00%)

0.05 (-76.19%)

0.21 (-83.57%)

1.28 (-44.96%)

Price to Book Ratio (P/B)

0.59 (281.17%)

0.15 (-74.38%)

0.6 (-34.46%)

0.92 (-48.97%)

Debt to Equity Ratio (D/E)

3.26 (32.18%)

2.47 (17.14%)

2.11 (126.21%)

0.93 (51.88%)

Earnings Per Share (EPS)

-2.86 (44.03%)

-5.11 (93.10%)

-74.01 (-6.34%)

-69.6 (-15.61%)

Sales Per Share (SPS)

14.63 (-54.51%)

32.16 (-51.11%)

65.77 (-16.09%)

78.38 (-35.90%)

Free Cash Flow Per Share (FCFPS)

-0.25 (83.66%)

-1.54 (92.17%)

-19.61 (36.76%)

-31.01 (75.31%)

Book Value Per Share (BVPS)

5 (-57.53%)

11.78 (-60.91%)

30.14 (-81.65%)

164.29 (-60.93%)

Tangible Assets Book Value Per Share (TABVPS)

11.85 (-48.91%)

23.2 (-49.09%)

45.58 (-66.64%)

136.63 (-59.56%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0.00%)

-1 (0%)

0 (0%)

-2 (77.78%)

Enterprise Value Over EBITDA (EV/EBITDA)

-13.06 (-798.69%)

-1.45 (-485.89%)

-0.25 (89.46%)

-2.35 (84.64%)

Asset Turnover

0.63 (-15.13%)

0.75 (46.47%)

0.51 (63.99%)

0.31 (17.36%)

Current Ratio

0.99 (-5.69%)

1.05 (13.44%)

0.93 (-3.33%)

0.96 (-63.31%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$1,388,000 (72.94%)

-$5,129,000 (82.21%)

-$28,823,000 (-11.01%)

-$25,964,000 (8.49%)

Enterprise Value (EV)

$13,215,021 (10.46%)

$11,963,286 (-51.17%)

$24,501,664 (-78.68%)

$114,915,095 (-5.13%)

Earnings Before Tax (EBT)

-$14,076,000 (17.45%)

-$17,051,000 (84.34%)

-$108,889,000 (-87.64%)

-$58,030,000 (-326.03%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$1,012,000 (87.71%)

-$8,236,000 (91.66%)

-$98,743,000 (-102.22%)

-$48,829,000 (-517.54%)

Invested Capital

-$1,463,000 (-178.91%)

$1,854,000 (34.64%)

$1,377,000 (106.83%)

-$20,155,000 (-262.13%)

Working Capital

-$337,000 (-108.83%)

$3,817,000 (184.58%)

-$4,513,000 (-7.35%)

-$4,204,000 (-109.01%)

Tangible Asset Value

$65,642,000 (-15.29%)

$77,493,000 (15.68%)

$66,991,000 (-41.44%)

$114,402,000 (49.84%)

Market Capitalization

$16,259,021 (168.82%)

$6,048,286 (-77.28%)

$26,616,664 (-78.89%)

$126,104,686 (-26.16%)

Average Equity

$30,878,250 (-29.19%)

$43,608,500 (-45.91%)

$80,622,000 (-33.44%)

$121,118,232 (142.48%)

Average Assets

$127,773,750 (-11.13%)

$143,778,750 (-24.13%)

$189,500,500 (-10.32%)

$211,309,339 (102.33%)

Invested Capital Average

$172,250 (-97.18%)

$6,101,500 (289.06%)

-$3,227,250 (-146.40%)

$6,955,965 (1105.28%)

Shares

5,568,158 (47.30%)

3,780,179 (95.99%)

1,928,744 (53.25%)

1,258,530 (109.30%)